with greater aggressiveness, even after seemingly successful treatment. An emerging area of research points to a small but influential population of cells known as cancer stem cells (CSCs). These cells are not the bulk of the tumor that most treatments target; instead, they function as a hidden command center, capable of initiating tumor regrowth and promoting resistance to therapy.
According to ResearchIntelo, the global cancer stem cell therapeutics market, valued at USD 1.48 billion in 2024, is projected to reach USD 4.39 billion by 2033, registering a CAGR of 12.8%. This growth reflects a strategic shift in cancer care, moving toward interventions that address the root cause of recurrence and metastasis.
Why Cancer Stem Cells Matter
In many ways, traditional cancer treatment resembles cutting weeds at the surface. While the visible growth is removed, the underlying roots remain. CSCs are those roots.
Unlike regular cancer cells, CSCs possess the ability to…
Learners at the College of Contract Management benefit from continuous academic support. Tutors guide students throughout their studies. This ensures learning objectives are met. Ongoing support plays a key role in student success.